Mettrum Health Arranges $10-million Bought Deal

Mettrum Health Corp. (TSXV:MT.V) has entered into an agreement with a syndicate of underwriters led by Cormark Securities Inc., pursuant to which the underwriters have agreed to purchase 3,774,000 common shares of Mettrum at a purchase price of $2.65 per share for aggregate gross proceeds of $10,001,100.
In addition, the Company has granted the Underwriters an option (“Over-Allotment Option”) to purchase up to an additional 566,100 Shares from the treasury of the Company at the offering price exercisable at any time up to 30 days following Closing (as defined below), for market stabilization purposes and to cover over-allotments, if any.
The net proceeds of the Offering will be used for plant expansion, including additional growing and oil extraction capacity at existing facilities, marketing & branding initiatives and other growth opportunities and general corporate purposes.
Connect with Mettrum Health Corp. (TSXV:MT.V) to receive an Investor Presentation.